Gene · 501
Papers3,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radiosynthesis and Preclinical Evaluation of an 18F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A). | Pharmaceuticals (Basel) | 2022 | 36297384 | PubTator, text mining | PubMed |
| SCN1B Genetic Variants: A Review of the Spectrum of Clinical Phenotypes and a Report of Early Myoclonic Encephalopathy. | Children (Basel) | 2022 | 36291443 | PubTator, text mining | PubMed |
| The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: A systematic review and meta-analysis. | Front Pharmacol | 2022 | 36278224 | PubTator, text mining | PubMed |
| The regulatory role of PDE4B in the progression of inflammatory function study. | Front Pharmacol | 2022 | 36278172 | PubTator, text mining | PubMed |
| Continuous-flow left ventricular assist device treatment for arrhythmogenic right ventricular cardiomyopathy complicated by advanced biventricular failure - University of Tokyo experiences. | Front Cardiovasc Med | 2022 | 36277799 | PubTator, text mining | PubMed |
| cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor. | Front Endocrinol (Lausanne) | 2022 | 36277728 | PubTator, text mining | PubMed |
| A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies. | Theranostics | 2022 | 36276649 | PubTator, text mining | PubMed |
| Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders. | Inflammopharmacology | 2022 | 36272040 | PubTator, text mining | PubMed |
| Purine metabolism in the development of osteoporosis. | Biomed Pharmacother | 2022 | 36271563 | PubTator, text mining | PubMed |
| Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer's disease. | Front Aging Neurosci | 2022 | 36268188 | PubTator, text mining | PubMed |
| A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing. | J Pathol Inform | 2022 | 36268089 | PubTator, text mining | PubMed |
| A positive feedback loop mediates crosstalk between calcium, cyclic nucleotide and lipid signalling in calcium-induced Toxoplasma gondii egress. | PLoS Pathog | 2022 | 36265000 | PubTator, text mining | PubMed |
| ALDH7A1 rs12514417 polymorphism may increase ischemic stroke risk in alcohol-exposed individuals. | Nutr Metab (Lond) | 2022 | 36258220 | PubTator, text mining | PubMed |
| Charge-Dipole Attraction as a Surface Interaction between Water Droplets Immersed in Organic Phases. | Langmuir | 2022 | 36256832 | PubTator, text mining | PubMed |
| Genetic heterogeneity in corpus callosum agenesis. | Front Genet | 2022 | 36246626 | PubTator, text mining | PubMed |
| Single-cell sequencing and establishment of an 8-gene prognostic model for pancreatic cancer patients. | Front Oncol | 2022 | 36237305 | PubTator, text mining | PubMed |
| Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters. | Int J Mol Sci | 2022 | 36232719 | PubTator, text mining | PubMed |
| Functional Downregulation of PD-L1 and PD-L2 by CpG and non-CpG Oligonucleotides in Melanoma Cells. | Cancers (Basel) | 2022 | 36230620 | PubTator, text mining | PubMed |
| Draft Genome Sequence of Endophytic Sphingomonas faeni Strain ALB2, Isolated from the Leaf of a Cold-Desert Medicinal Plant. | Microbiol Resour Announc | 2022 | 36227099 | PubTator, text mining | PubMed |
| Metagenomic analysis of the soil microbial composition and salt tolerance mechanism in Yuncheng Salt Lake, Shanxi Province. | Front Microbiol | 2022 | 36225369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/501/papers?page=37